Adaptimmune Therapeutics

NASDAQ: ADAP · Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM

ADAP Insider Trading

We track 542 insider transactions spanning 103 purchases and 133 sales, with a total transaction value of $664.3M. Recent activity shows 0 transactions in the last 90 days, indicating insider distribution among company executives and key stakeholders.

542 Transactions

Name Transaction Date Shares Price Value Type
Bertrand William C Jr Chief Operating Officer
Feb 20, 2025 1,612,032 $0.10 $161,203.2 A-Award
Bertrand William C Jr Chief Operating Officer
Feb 20, 2025 1,074,696 $0.00 $1,397.105 A-Award
Brewer Joanna Elizabeth Chief Scientific Officer
Feb 20, 2025 1,612,032 $0.10 $161,203.2 A-Award
Brewer Joanna Elizabeth Chief Scientific Officer
Feb 20, 2025 1,074,696 $0.00 $1,397.105 A-Award
Lunger John Chief Patient Supply Officer
Feb 20, 2025 1,612,032 $0.10 $161,203.2 A-Award
Lunger John Chief Patient Supply Officer
Feb 20, 2025 1,074,696 $0.00 $1,397.105 A-Award

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access to all data and tools
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Realtime Options & Dark Pool Data
Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
Top Wallstreet Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.